Aurobindo Pharma Ltd.

In News

Aurobindo Pharma shares in focus after Q3 results; this brokerage maintains a bullish view — more details inside - MSN

MSN - Feb 15, 2026

Earnings To Watch: Aurobindo Pharma Ltd (NSE:AUROPHARMA) Reports Q3 2026 Result - GuruFocus

GuruFocus - Feb 10, 2026

Analysts Have Made A Financial Statement On Aurobindo Pharma Limited's (NSE:AUROPHARMA) Third-Quarter Report - simplywall.st

simplywall.st - Feb 12, 2026

Aurobindo Pharma: US FDA Issues Form 483 With 9 Procedural Observations - Whalesbook

Whalesbook - Feb 10, 2026

Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment - scanx.trade

scanx.trade - Feb 13, 2026

Aurobindo Pharma arm Acrotech gets FDA nod for eczema ointment ADQUEY - CNBC TV18

CNBC TV18 - Feb 13, 2026

Aurobindo Pharma formulations facility gets 11 observations from FDA - ET Pharma

ET Pharma - Feb 08, 2026

BDA advises Khandelwal Labs on sale of non-oncology branded generics business to Aurobindo - BDA Partners

BDA Partners - Jan 05, 2026

Aurobindo Pharma Says Surge in Share Volume Is Market Driven, Not Due to Undisclosed Events - TipRanks

TipRanks - Jan 30, 2026

Aurobindo Pharma Gets 11 USFDA Observations at Eugia Unit - Medical Dialogues

Medical Dialogues - Feb 08, 2026

Aurobindo Unit 7 Gets 9 FDA Observations; Shares Rise 2.75% - Equitypandit

Equitypandit - Feb 11, 2026

Aurobindo Pharma share price falls 6.46% today, stock among top losers on Nifty Midcap 150 - Moneycontrol

Moneycontrol - Feb 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment